⚠️

Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.

Read our methodology →

John ZippererMD

Internal Medicine · Los Angeles, CA 90049

NPI: 1649212770

Share:

36

🟠 Elevated

🤖 ML Fraud Detection Score: 88%

Machine learning model identifies prescribing patterns consistent with confirmed fraud cases. This is a statistical indicator, not an accusation.

Learn more →

Risk Flags

Extreme opioid rate vs specialty peersHigh long-acting opioid rate vs peersHigh fills per patient

Risk indicators are statistical patterns, not allegations. Learn more

530

Total Claims

$31K

Drug Cost

21

Beneficiaries

$1,463

Cost/Patient

Risk Score Breakdown 36/100

Low (0)Moderate (15)Elevated (30)High (50+)
Opioid rate vs specialty peers+25
Long-acting opioid rate+8
High fills per patient+3

Score components are additive. Read full methodology

Peer Comparison vs. 110,156 Internal Medicine providers

+1291%

Opioid rate vs peers

31.1% vs 2.2% avg

+4%

Cost per patient vs peers

$1,463 vs $1,411 avg

-63%

Brand preference vs peers

4.0% vs 10.6% avg

⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.

🔎 Data Overview

🤖

ML fraud detection score of 88% indicates prescribing patterns with significant similarity to confirmed fraud cases. 18 out of 20 decision trees flagged this provider.

⚠️

Opioid prescribing rate is 1,291% above the average for Internal Medicine providers. While some providers legitimately treat pain-heavy populations, deviations of this magnitude are rare and warrant examination.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Opioid Prescribing

31.1%

Opioid Rate

165

Opioid Claims

$18K

Opioid Cost

37.6%

Long-Acting Rate

This provider's opioid prescribing rate of 31.1% is above the 20% threshold that CMS considers elevated.

Brand vs Generic

96% generic

Brand: 21 claims · $2,097

Generic: 509 claims · $29K

Patient Profile

65

Avg Age

Female

1.38

Avg Risk Score

Explore More

Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About